The FDA has rejected more than a million vaping products with flavors like “Jimmy the Juice Man Peachy Strawberry” and ...

Protagonist (Nasdaq: PTGX) is one of a handful of Bay Area drug developers ready to ask the Food and Drug Administration to ...

The Supreme Court sided with a former commercial truck driver Wednesday who was fired after failing a drug test he said was ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

The University of Kentucky's Center for Clinical and Translational Science brought together around 1,000 clinicians, ...

Lexicon Pharmaceuticals, headquartered in The Woodlands, announced it will exclusively license its drug LX9851 to the maker ...

Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment ...

President Donald Trump's proposed tariffs could raise the cost of some cancer treatments by as much as $10,000, while also ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

Pharmaceutical companies and precision medicine companies could also use the data to develop new drugs. It wouldn’t be the ...

With growing bipartisan support, there’s an opportunity to tackle these issues head-on, and leaders in the healthcare space ...